± SCIENCE Today’s artificial intelligence still faces two major challenges. One is that, in most industries, data exist…+ SCIENCE Deep learning takes on protein folding In 1972, Anfinsen won a Nobel prize for demonstrating a connection bet…± SCIENCE Significance Deep neural networks are currently the most successful machine-learning technique for solving a…+ SCIENCE Deep learning allows computational models that are composed of multiple processing layers to learn representa…+ HEALTH For the task of analyzing survival data to derive risk factors associated with mortality, physicians, researc…+ SCIENCE Artificial intelligence (AI) coupled with promising machine learning (ML) techniques well known from computer…+ SCIENCE Deep learning is revolutionizing many areas of science and technology, especially image, text, and speech rec…+ SCIENCE Current deep-learning models are mostly built upon neural networks, i.e. multiple layers of parameterized dif…
TruaceTracing the truth around AIMonday, July 13, 2026
Subscribe
TRV-2026-0192Certified recordPeer-reviewed

AI-driven multimodal retinal imaging for early detection and risk stratification of vascular and neurodegenerative diseases

Systemic vascular and neurodegenerative disorders are important causes of disability and death worldwide, mainly because of the late stage of diagnosis and the high cost of current screening tools. Artificial intelligence (AI) and multimodal retinal imaging offer a non-invasive and viable approach for early risk stratification and longitudinal monitoring. This review highlights how changes in the retinal vasculature and nerve layers are markers of underlying pathophysiologies related to cardiovascular, metabolic…

Health · The Trace — both readings · certified 2026-07-13 · v1 · article view · machine-readable

Current reading — gain

AI combined with multimodal retinal imaging provides a non-invasive method for early risk stratification and screening for cardiovascular, metabolic and neurodegenerative disorders using retinal vasculature and nerve layer changes.

Current reading — problem

AI-assisted retinal analysis faces implementation hurdles including lack of multicenter validation, need for prospective clinical trials, and unresolved data fusion and regulatory requirements.

What this doesn’t fix

Clinical translation is limited by need for multicenter validation, prospective trials, data fusion challenges and regulatory frameworks.

Evidence

Reader signal

How should this claim be treated?

Cite this record

Truvace Impact Record TRV-2026-0192, v1: “AI-driven multimodal retinal imaging for early detection and risk stratification of vascular and neurodegenerative diseases.” Truvace, 2026-07-13. /record/TRV-2026-0192 (accessed at citation time). sha256 960b16fb94aa7d0e…

Calibration history

Every change to this record since certification, in the open. None yet — the reading has held since it entered the record.

  1. Certifiedv1960b16fb94aa…

    Certified into the record

Verify this record
How to verify without trusting this page

Fetch the canonical text of any version from /api/record/TRV-2026-0192 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.